Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23218046 | 0.77 | CYP17A1 (0.36) | CYP17A1CYP19A1 | |
| SCHEMBL29853117 | 0.70 | CYP17A1 (0.37) | CYP17A1CYP19A1 | |
| SCHEMBL28736125 | 0.70 | CYP17A1 (0.37) | CYP17A1CYP19A1 | |
| SCHEMBL23218931 | 0.70 | CYP17A1 (0.37) | CYP17A1CYP19A1 | |
| SCHEMBL23219106 | 0.69 | CYP17A1 (0.32) | CYP17A1CYP19A1 | |
| SCHEMBL23219105 | 0.68 | — | — | |
| SCHEMBL28485830 | 0.66 | TLR7 (0.35) | — | |
| SCHEMBL1863458 | 0.65 | MAOB (0.33) | — | |
| SCHEMBL5987472 | 0.64 | ALDH1A1 (0.39) | — | |
| SCHEMBL3759169 | 0.61 | ESR1 (0.33) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4041238-A1 | ORAL COMPLEMENT FACTOR D INHIBITORS | Biocryst Pharmaceuticals, Inc. (US) | 2022-08-17 | — | — | EP | disclosed |